drugset / Trial / NCT01854567

P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies

NCT01854567 ↗

Phase 3 Completed 49 enrolled Mesoblast, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The study investigates the time to engraftment of a mesenchymal expanded cord blood unit in patients with hematologic malignancies undergoing transplantation with myeloablative conditioning.

Timeline

Start
2013-08
Primary completion
2016-09-23
Completion
2017-05-05

Drugs

EvaluationDrugModalityDoseRoute
Subject MPC expanded cord unit Unknown — —
Comparator unexpanded cord blood unit Unknown — —
Subject unexpanded cord unit Unknown — —